HOUSE_OVERSIGHT_024724.jpg
2.13 MB
Extraction Summary
0
People
7
Organizations
0
Locations
0
Events
3
Relationships
3
Quotes
Document Information
Type:
Investment report page
File Size:
2.13 MB
Summary
This page from an Ackrell Capital investment report outlines three potential regulatory scenarios for the future of cannabis in the United States. It details hypothetical frameworks for the FDA routine approval of CBD and THC drugs, as well as a broader scenario where the federal government fully legalizes cannabis and establishes a new regulatory agency.
Organizations (7)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital | ||
| Ackrell Capital, LLC | ||
| FDA | ||
| DEA | ||
| Federal Government | ||
| FINRA | ||
| SIPC |
Relationships (3)
→
→
→
→
→
→
Key Quotes (3)
"The FDA will adopt procedures for the routine approval of drugs that contain extracts of certain low-THC/high-CBD FDA-registered chemovars."Source
HOUSE_OVERSIGHT_024724.jpg
Quote #1
"Parts and derivatives of the cannabis plant will be removed from the CSA schedules."Source
HOUSE_OVERSIGHT_024724.jpg
Quote #2
"once the entire cannabis plant is de-scheduled, a new federal cannabis agency will be established to regulate medical and recreational cannabis"Source
HOUSE_OVERSIGHT_024724.jpg
Quote #3
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document